Green Cross Lab Cell Corporation (144510) — Cash Flow-to-Debt Ratio
Green Cross Lab Cell Corporation (144510) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of ₩6.67 Billion could theoretically repay 0% of its total liabilities (₩134.23 Billion) in one year. Explore Green Cross Lab Cell Corporation long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Green Cross Lab Cell Corporation Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Green Cross Lab Cell Corporation across 10 annual periods. Also explore Green Cross Lab Cell Corporation (144510) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Green Cross Lab Cell Corporation (2015–2024)
Year-by-year debt coverage analysis for Green Cross Lab Cell Corporation. For market capitalisation and broader financial context, see market value of Green Cross Lab Cell Corporation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | ₩11.34 Billion | ₩120.56 Billion | ▲ +217.0% |
| 2023 | 0.03x | ₩3.67 Billion | ₩123.69 Billion | ▼ -93.8% |
| 2022 | 0.48x | ₩66.42 Billion | ₩138.07 Billion | ▲ +170.8% |
| 2021 | 0.18x | ₩23.91 Billion | ₩134.57 Billion | ▼ -43.0% |
| 2020 | 0.31x | ₩9.09 Billion | ₩29.19 Billion | ▲ +3254.2% |
| 2019 | 0.01x | ₩223.04 Million | ₩24.02 Billion | ▼ -81.9% |
| 2018 | 0.05x | ₩490.92 Million | ₩9.55 Billion | ▼ -87.4% |
| 2017 | 0.41x | ₩2.86 Billion | ₩7.03 Billion | ▲ +980.1% |
| 2016 | -0.05x | ₩-296.65 Million | ₩6.42 Billion | ▼ -124.6% |
| 2015 | 0.19x | ₩1.49 Billion | ₩7.90 Billion | — |